03.20.06

Epigenetics explored at McGill University

Posted in news links at 8:58 pm by admin

Dr. Moshe Szyf and colleagues at McGill University in Montreal are conducting research in the area of epigenetics, reports Globe and Mail. Dr. Szyf and his team are involved in the development of an epigenetic cancer drug in clinical trials that aims to turn on the methylated genes that inhibit tumor growth in cancer patients. In addition, Dr. Szyf’s team at McGill are exploring how epigenetics may play a role when cancer metastasizes.